These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 21402116

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL.
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [Abstract] [Full Text] [Related]

  • 3. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD, Aitken JF, Bailey RJ, Poyner DR, Hay DL.
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [Abstract] [Full Text] [Related]

  • 4. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
    Watkins HA, Walker CS, Ly KN, Bailey RJ, Barwell J, Poyner DR, Hay DL.
    Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB, Wetzel-Strong SE, Dunn MK, Caron KM.
    Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
    [Abstract] [Full Text] [Related]

  • 7. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
    Booe JM, Warner ML, Roehrkasse AM, Hay DL, Pioszak AA.
    Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM, Luessi F, Koller D, Born W, Fischer JA, Muff R.
    Biochem Biophys Res Commun; 2004 Jul 09; 319(4):1203-9. PubMed ID: 15194494
    [Abstract] [Full Text] [Related]

  • 10. Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3'5'-monophosphate generation in Eker rat uterine smooth muscle cell line.
    Thota C, Yallampalli C.
    Biol Reprod; 2005 Feb 09; 72(2):416-22. PubMed ID: 15469997
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.
    Kuwasako K, Kitamura K, Nagata S, Nozaki N, Kato J.
    Biochem Biophys Res Commun; 2012 Apr 13; 420(3):582-7. PubMed ID: 22445753
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Shared and separate functions of the RAMP-based adrenomedullin receptors.
    Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Takei Y, Kato J.
    Peptides; 2011 Jul 13; 32(7):1540-50. PubMed ID: 21645567
    [Abstract] [Full Text] [Related]

  • 14. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
    Edvinsson L, Eftekhari S, Salvatore CA, Warfvinge K.
    Mol Cell Neurosci; 2011 Jan 13; 46(1):333-9. PubMed ID: 21040789
    [Abstract] [Full Text] [Related]

  • 15. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
    Roehrkasse AM, Booe JM, Lee SM, Warner ML, Pioszak AA.
    J Biol Chem; 2018 Oct 12; 293(41):15840-15854. PubMed ID: 30139742
    [Abstract] [Full Text] [Related]

  • 16. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
    Udawela M, Christopoulos G, Morfis M, Christopoulos A, Ye S, Tilakaratne N, Sexton PM.
    Mol Pharmacol; 2006 Nov 12; 70(5):1750-60. PubMed ID: 16912219
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
    Hay DL, Walker CS, Poyner DR.
    Endocr Relat Cancer; 2011 Feb 12; 18(1):C1-14. PubMed ID: 21051558
    [Abstract] [Full Text] [Related]

  • 19. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
    Hay DL, Christopoulos G, Christopoulos A, Sexton PM.
    Mol Pharmacol; 2006 Dec 12; 70(6):1984-91. PubMed ID: 16959943
    [Abstract] [Full Text] [Related]

  • 20. Functional characterization of two human receptor activity-modifying protein 3 variants.
    Bailey RJ, Bradley JW, Poyner DR, Rathbone DL, Hay DL.
    Peptides; 2010 Apr 12; 31(4):579-84. PubMed ID: 20034525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.